These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 14441242)
21. Effect of uracil mustard in chronic lymphatic leukemia and malignant lymphoma. KENNEDY BJ; THEOLOGIDES A Cancer Chemother Rep; 1961 Apr; 11():77-80. PubMed ID: 13752495 [No Abstract] [Full Text] [Related]
22. Phenylbutazone (butazolidin), a useful chemotherapeutic agent for Hodgkin's disease. ROTTINO A; JOFFE A; HOFFMANN G AMA Arch Intern Med; 1954 Apr; 93(4):561-70. PubMed ID: 13137632 [No Abstract] [Full Text] [Related]
23. [Value and action of cytostatics in malignant lymphatic system diseases]. FLEISCHHACKER H; STACHER A Wien Z Inn Med; 1962 May; 43():200-8. PubMed ID: 13893500 [No Abstract] [Full Text] [Related]
24. [On dopan therapy of patients with lymphogranulomatosis, chronic lymphatic leukemia and other systemic blood diseases]. PETROV KIa Sov Med; 1961 Nov; 25():13-7. PubMed ID: 14485925 [No Abstract] [Full Text] [Related]
25. [On the use of high doses of cytostatic target therapy and autologous bone marrow transplantation in malignant lymphoreticulum diseases]. PESCHL L; REIMER EE; SIMON W Krebsarzt; 1962 Apr; 17():147-54. PubMed ID: 14485656 [No Abstract] [Full Text] [Related]
26. [Chemotherapeutic treatment of Hodgkin's disease in the past decade]. CAMPIGLIO A Farmaco Prat; 1960 Aug; 15():496-8. PubMed ID: 14448590 [No Abstract] [Full Text] [Related]
27. Chemotherapeutic management of lymphomas; effect upon survival. SHIMKIN MB Acta Unio Int Contra Cancrum; 1955; 11(3):318-28. PubMed ID: 13326623 [No Abstract] [Full Text] [Related]
28. Management of the patient with Hodgkin's disease. GELLHORN A J Chronic Dis; 1955 Jun; 1(6):698-705. PubMed ID: 14381503 [No Abstract] [Full Text] [Related]
29. New nitrogen mustards in the management of Hodgkin's disease. SAMPEY JR Am J Pharm Sci Support Public Health; 1960 Jun; 132():231-8. PubMed ID: 14441250 [No Abstract] [Full Text] [Related]
30. Management of late Hodgkin's disease. Br Med J; 1970 Jul; 3(5713):2. PubMed ID: 5427485 [No Abstract] [Full Text] [Related]
31. Management of human leukemias and Hodgkin's disease with Dopan (uracil mustard). SAMPEY JR J S C Med Assoc; 1962 May; 58():175-6. PubMed ID: 14496660 [No Abstract] [Full Text] [Related]
32. The value of combined treatment in management of Hodgkin's disease. Patrício MB; Vilhena M; de Ponte MA; Cabral R; Simões MJ; Branco F; Ricardo JA Nihon Gan Chiryo Gakkai Shi; 1982 Jun; 17(4):1016-22. PubMed ID: 7130791 [No Abstract] [Full Text] [Related]
33. [Current treatment of Hodgkin's disease]. Ikkala E Duodecim; 1974; 90(3):165-7. PubMed ID: 4848417 [No Abstract] [Full Text] [Related]
34. Current concepts of cancer chemotherapy. PAPAC RJ; WOOD DA Calif Med; 1962 Jun; 96(6):420-5. PubMed ID: 14483658 [TBL] [Abstract][Full Text] [Related]
35. Diagnosis and treatment of Hodgkin's disease. Canellos GP Med Times; 1978 Mar; 106(3):30-5. PubMed ID: 634096 [No Abstract] [Full Text] [Related]
36. [Favorable development of Hodgkin's disease treated with E 39]. ZAIMI A; BEN ABDALLAH T; LEGROS N Tunis Med; 1958 Jun; 36(6):331 passim. PubMed ID: 13592972 [No Abstract] [Full Text] [Related]
37. [Treatment of Hodgkin's disease. General principles]. Bernard J Rev Prat; 1974 Oct; 24(45):3933-4, 3939-40. PubMed ID: 4216951 [No Abstract] [Full Text] [Related]
38. [Modern classification of Hodgkin's disease and new trends in its therapy]. Policlinico Prat; 1968 Dec; 75(49):1623-9. PubMed ID: 4973411 [No Abstract] [Full Text] [Related]
39. Combined modality in advanced Hodgkin's disease. Baumann M; Herrmann T; Thames HD J Clin Oncol; 1998 Aug; 16(8):2893-4. PubMed ID: 9704747 [No Abstract] [Full Text] [Related]
40. The management of Hodgkin's disease. Rosenberg SA N Engl J Med; 1978 Nov; 299(22):1246-7. PubMed ID: 714082 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]